undefined
null (null%)
At close: Invalid Date

Company Description

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide.

It operates in Commercial Pharmaceuticals and Manufacturing segments.

The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.

It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor.

In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers.

The company was founded in 1850 and is headquartered in Durban, South Africa.

 logo
Country ZA
IPO Date Apr 5, 2010
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 8,867
CEO Stephen Bradley Saad BCom, CA(SA)

Contact Details

Address:
Aspen Place
Durban,
ZA
Website https://www.aspenpharma.com

Stock Details

Ticker Symbol APNHY
Exchange PNK
Fiscal Year July - June
Reporting Currency USD
CIK Code n/a
CUSIP Number 04530Y106
ISIN Number US04530Y1064
Employer ID -
SIC Code n/a

Key Executives

Name Position
Samer Kassem Chief Executive Officer of Aspen Global Incorporated
Stephen Bradley Saad BCom, CA(SA) Group Chief Executive Officer & Executive Director
Trevor Julian Ziman Regional Chief Executive Officer of Asia Pacific
Sean M. Capazorio Group Chief Financial Officer & Executive Director
Lorraine Hill Group Chief Operations Officer
Michael Guy Attridge B.Com., CA(SA) Group Chief Advisor
Raeesa Khan Group Company Secretary & Chief of Staff
Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA Group Chief Corporate Officer & Executive Director
Sibongakonke Nkosi Investor Relations Manager
Zizipho Mmango Group Chief Strategic Development Officer

Latest SEC Filings

No SEC filings available.